La Caixa Foundation Promotes Research in Biomedicine and Health with €25.3 Million

Millions to be invested in the biotech sector. The La Caixa Foundation has provided aid to 33 research projects in biomedicine and health that will be carried out in research centers, hospitals, and universities in Spain and Portugal. The call is endowed with €25.3 million.

These are projects selected within the framework of the CaixaResearch call for Health Research 2023, which has the objective of promoting excellent biomedical research with great social impact in basic, clinical, and translational research.

The call, to which 493 proposals had been submitted this year, is especially aimed at addressing health challenges, such as infectious diseases (an area in which eight projects have been chosen), neurosciences (seven), cardiovascular diseases and related metabolic diseases (seven) and oncology (six). In addition, five other award-winning initiatives will develop enabling technologies in one of these fields.

Read more about La Caixa Foundation and the recent allocation of €25.3 million for research and find the most important financial news of the day with the Born2Invest mobile app.

La Caixa Foundation supports projects on infectious diseases, neurosciences, or oncology, among others

One of the challenges is to achieve greater financial support for research so that it can be carried out in a stable manner. Precisely to help at this point, in the La Caixa Foundation call, 22 projects are led by Spanish centers, while eleven initiatives are from Portugal.

The work will be carried out over the next three years. The grants provide financial support of up to €500,000 for projects presented by a single research organization and up to €1 million for projects presented by consortia of between two and five research organizations.

The initiative is carried out in collaboration with the Fundação para a Ciência ea Tecnologia (FCT), of the Ministry of Science, Technology and Higher Education of Portugal, which provides €3.7 million to subsidize five of the eleven Portuguese projects selected in this edition. The call is also supported by the Luzón Foundation, which subsidizes, together with the La Caixa Foundation, a project on amyotrophic lateral sclerosis (ALS).

Since the beginning of the program in 2018, the total allocation of the call has been €120.5 million for 171 projects, 117 of them led by Spanish teams, and 54 by research groups from Portugal. Currently, this is the most important philanthropic call for research in biomedicine and health in Spain and Portugal.

__

(Featured image by jarmoluk via Pixabay)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in PlantaDoce. A third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.